Association of tumor necrosis factor alpha -238G/A and -308G/A promotor polymorphisms with clearance of Hepatitis B virus infection in Turkish population

Authors

  • Ahmet Çağkan İnkaya
  • Emel Türk Arıbaş
  • İbrahim Erayman
  • Hasan Acar
  • Bahar Kandemir
  • Mehmet Bitirgen

DOI:

https://doi.org/10.32552/2019.ActaMedica.341

Abstract

Aim: Acute viral hepatitis B may lead to chronic hepatitis in 6% of adult population. We compared the frequency of Tumor necrosis factor alpha promotor polymorphisms in chronic hepatitis B patients and people with natural immunity against hepatitis B.

Material and Methodology: Chronic hepatitis B patients and age matched control cases with natural immunity to hepatitis B virus were recruited 1:1 in this study. Tumor necrosis factor alpha -238G/A and -308G/A polymorphisms were studied with PCR-RFLP. χ2 test was performed in statistical analysis.

Results: A total of 101 volunteers enrolled in two study groups. Thirty-eight men and 12 women constituted the chronic hepatitis B patient group and 40 men and 11 women recruited in natural immunity group. Frequency of -238G allele was 87.5% and 97% in chronic hepatitis B and natural immunity groups, respectively. Frequency of -308G allel was 93% and 92.1% in chronic hepatitis B and natural immunity groups, respectively. Frequencies of polymorphisms at positions -238 and -308 in the promotor of tumor necrosis factor alpha gene were not different between chronic hepatitis B and natural immunity groups.

Conclusion: Tumor necrosis factor alpha promoter polymorphisms at -238 and -308 positions do not effect the outcome hepatitis B infection in Turkish population. Clearance of hepatitis B virus infection is multifactorial. Thus, further studies needed to identify genetic predisposition to chronic hepatitis B infection.

Downloads

Download data is not yet available.

Downloads

Published

2019-03-30

How to Cite

1.
İnkaya AÇ, Türk Arıbaş E, Erayman İ, Acar H, Kandemir B, Bitirgen M. Association of tumor necrosis factor alpha -238G/A and -308G/A promotor polymorphisms with clearance of Hepatitis B virus infection in Turkish population. Acta Medica [Internet]. 2019 Mar. 30 [cited 2024 Feb. 27];50(1):1-6. Available from: https://actamedica.org/index.php/actamedica/article/view/341

Issue

Section

Original Article